We have 1061 guests and no members online

Cuba's Drug Itolizumab Wins Gold Medal
psoriasis medicamento cubano f cubasiCuban medicine Itolizumab was awarded with the Gold Medal of the World Intellectual Property Organization (WIPO), in a ceremony held on the presence of Miguel Diaz-Canel Bermudez, First Vice President of the Councils of State and Ministers.
Holguin's Infant Mortality Rate Remains Low in 2015
Holguin Develops Eighth Clinical Trial at CIRAH

The Itolizumab is a humanized monoclonal antibody that recognizes the CD6 leukocyte antigen for the treatment of autoimmune diseases, psoriasis specifically said the MSc. María de los Angeles Sanchez Torres, director of the Cuban Office of Industrial Property.

This is a product that is indicated for severe psoriasis, a chronic inflammatory skin disease that affects about 125 million people worldwide, she explained.

The ceremony that was held at the Jose Marti Memorial in Havana, was also attended by Elba Rosa Perez Montoya, member of the Central Committee and Minister of Science, Technology and Environment (CITMA), and other leaders, and it is a recognition of the constant advances in the scientific branch of the country and its application to public health. / Source: RHC / Translated by Liubis Balart Martinez - Radio Guantanamo.

Leave your comments

Post comment as a guest

0 / 500 Character restriction
Your text should be less than 500 characters

Comments

  • No comments found